Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Death on an LVAD-Two sides of a coin.

Phan JA, Muthiah K, Robson D, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Dhital K, Granger E, Jansz P, Hayward CS.

Heart Lung Circ. 2013 Nov;22(11):952-4. doi: 10.1016/j.hlc.2013.02.001.

PMID:
23506725
2.

Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2004;4(3):1-69.

3.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

4.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037.

5.

Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device.

Sims DB, Rosner G, Uriel N, González-Costello J, Ehlert FA, Jorde UP.

Pacing Clin Electrophysiol. 2012 May;35(5):e144-8. doi: 10.1111/j.1540-8159.2011.03159.x.

PMID:
21679198
6.

Evolution of general surgical problems in patients with left ventricular assist devices.

McKellar SH, Morris DS, Mauermann WJ, Park SJ, Zietlow SP.

Surgery. 2012 Nov;152(5):896-902. doi: 10.1016/j.surg.2012.03.005.

PMID:
22575878
7.

Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant.

Helman DN, Addonizio LJ, Morales DL, Catanese KA, Flannery MA, Quagebeur JM, Edwards NM, Galantowicz ME, Oz MC.

J Heart Lung Transplant. 2000 Feb;19(2):121-6.

PMID:
10703686
8.

Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.

Kamdar F, Boyle A, Liao K, Colvin-adams M, Joyce L, John R.

J Heart Lung Transplant. 2009 Apr;28(4):352-9. doi: 10.1016/j.healun.2009.01.005.

PMID:
19332262
9.

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.

Circulation. 1994 Nov;90(5 Pt 2):II83-6.

PMID:
7955290
10.

Assessment of submaximal exercise capacity in patients with left ventricular assist devices.

Foray A, Williams D, Reemtsma K, Oz M, Mancini D.

Circulation. 1996 Nov 1;94(9 Suppl):II222-6.

PMID:
8901750
11.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.

Circulation. 2007 Jul 31;116(5):497-505.

12.

Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.

Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D.

Circulation. 2000 Nov 28;102(22):2713-9.

13.

Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?

Klotz S, Stypmann J, Welp H, Schmid C, Drees G, Rukosujew A, Scheld HH.

Ann Thorac Surg. 2006 Nov;82(5):1774-8.

PMID:
17062246
14.

The use of advance directives among patients with left ventricular assist devices.

Swetz KM, Mueller PS, Ottenberg AL, Dib C, Freeman MR, Sulmasy DP.

Hosp Pract (1995). 2011 Feb;39(1):78-84. doi: 10.3810/hp.2011.02.377.

PMID:
21441762
15.

Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.

Morgan JA, Brewer RJ, Nemeh HW, Murthy R, Williams CT, Lanfear DE, Tita C, Paone G.

ASAIO J. 2012 Nov-Dec;58(6):574-7. doi: 10.1097/MAT.0b013e31826e4267.

PMID:
23103696
16.

Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.

Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC, Ronan NS, Piccione W Jr, Holman WL, Furukawa S, Weinberg AD, Heatley G, Poirier VL, Damme L, Long JW.

Ann Thorac Surg. 2004 Dec;78(6):2123-9; discussion 2129-30.

PMID:
15561049
17.

Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.

Milano CA, Lodge AJ, Blue LJ, Smith PK, Felker GM, Hernandez AF, Rosenberg PB, Rogers JG.

N C Med J. 2006 Mar-Apr;67(2):110-5.

PMID:
16752713
18.

The dilemma of a left ventricular assist device explantation: a decision analysis.

Delgado DH, Ross HJ, Rao V.

Can J Cardiol. 2007 Jun;23(8):657-61.

19.

Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.

Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, Hayward CS.

J Heart Lung Transplant. 2011 Aug;30(8):888-95. doi: 10.1016/j.healun.2011.03.006.

PMID:
21530314
20.

[Mid-long term result of implantable ventricular assist device treatment for end-stage heart failure in the University of Tokyo Hospital].

Kinoshita O, Kimura M, Kashiwa K, Kubo H, Kagami Y, Endo M, Shiga T, Kinugawa K, Nishimura T, Kyo S, Komuro I, Ono M.

Kyobu Geka. 2013 Jan;66(1):51-6. Japanese.

PMID:
23985405
Items per page

Supplemental Content

Support Center